Isolagen Modifies Ongoing Clinical Program for ...(asis of a Phase III trial submission to ...),Health
Navigation Links
Isolagen Modifies Ongoing Clinical Program for Acne Scars
Date:11/27/2007
asis of a Phase III trial submission to the FDA.
"We appreciate the FDA's attention and guidance and are moving forward to modify our acne scar clinical program," said Nicholas L. Teti, Jr., Chairman and Chief Executive Officer of Isolagen. "Little scientific research has been done previously to establish clinical efficacy measurements in the area of acne scarring. We feel it is important to advance our technology in a new therapeutic category for this unmet need, and we will continue to collaborate with the FDA to move our program forward."
About Isolagen, Inc.
Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic company committed to developing and commercializing scientific advances and innovative technologies. The company's technology platform consists of the Isolagen Therapy. The Isolagen Therapy is a cellular processing system which creates a natural therapy of living cells by multiplying a patient's own collagen- producing cells or fibroblasts into tens of millions of new cells, creating a treatment which is then returned to the patient's skin. Clinical studies are currently underway investigating the Isolagen Therapy in aesthetic and therapeutic applications. Isolagen also commercializes a scientifically- advanced line of skincare systems through its majority-owned subsidiary, Agera(R) Laboratories, Inc. For additional information, please visit http://www.isolagen.com.
Isolagen Forward Looking Statements
All statements in this news release that are not based on historical
fact are "forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 and the provisions of Section 27A
of the
'/>"/>
| SOURCE Isolagen, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Isolagen, Inc. Postpones Annual Meeting
2. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
3. CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for Treatment-Resistant Depression Study
4. Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids
5. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Clinical depression linked to abnormal emotional brain circuits
8. Preclinical study suggests organ-transplant drug may aid in lupus fight
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Good Clinical Practice Journal Awards: Winners Announced
11. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
Post Your Comments:
(Date:11/22/2009)... HealthSmart, an innovati...ounced that it has successfully completed a recapi... Company’s other lenders. Silver Point Capi...eenwich, Connecticut. This recapitalization allow... its business strategy. , , ...
(Date:11/22/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewswi...following statement upon the United States Senate,...Health Care legislation: ,, "Senators Arlen Spe...hians and all Pennsylvanians for casting stand-up,...esident Obama,s historic Affordable Health Care Re...
(Date:11/21/2009)..., , "This bill provides for an unprece...t is health care about if it is not for preserving...nded, it must be defeated." Charmaine Yoest ,...Americans United for Life Action President and CEO...n the Senate by releasing the following statement:...
(Date:11/21/2009)..., , Association Discusses Key Provisions ...lth Care Reform ,, ST. CHARLES, Ill., Nov. 21 ...f Representatives passing the landmark Affordable ...enate moving key health reform legislation forward...ion,s broken health care system. Today, AARP host...
(Date:11/21/2009)... Innovative medical appar... conference , San Clement...g;, maker of breakthrough medical apparel, today a...are on display at Medica 2009, a leading internati...usseldorf, Germany. Medelita inaugurates its men,s...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3[1] HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman [0] Congressman Fattah: Thanks to Specter, Casey for a Major Step Along History's Path[0] Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill[0] AARP Hosts Rep. Bill Foster In Health Care Reform Forum[0] Medelita Introduces Men's Lab Coat Collection
...s Key Time to Start Talking With ,Tweens,: TimeToT...ols to Begin Middle School Safely ...any parents have a difficult,time talking to their...g ), -- a campaign celebrating the influence paren...
...ork, LLC Ranks No. 3,216 on the 2007 Inc. 5,000, N...-Year Sales Growth of 97.2%, PORTLAND, Ore., Sept...medical and health communications firm, No. 3,216 ...,500 list, catches many businesses that are too bi...
...dentialing Datasource(R) Saving Millions by Elimin...s, WASHINGTON, Sept. 5 CAQH announced today,that...ignificantly reducing,administrative burden by usi...provider directories. According to estimates from...
...- For lunch, Joy Hesemann loved to dive into a pla... side of ranch dressing. At night, she,d fry up gr...al for her family,s dinner. Later, she,d plop in f...d I wasn,t exercising," admitted Hesemann, 27, an ...
...ian patients seeking medical care for primary bili...red to Caucasian patients, a new study has found. ...the authors. These findings are in the September i...e is also available online at Wiley Interscience (...
...University study has found that removing indoor mo... Asthma UK figures show the prevalence of asthma ...60,000 people receiving treatment for their asthma...s with asthma living in two areas of South Wales i...
Other Medicine News:Health News:Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids 2Health News:Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids 3Health News:Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids 4Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 2Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 3Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 4Health News:Over 500,000 Health Care Providers Now Cutting Costs, Saving Time Through CAQH Administrative Simplification Initiative 2Health News:Farewell chicken tenders 2Health News:Farewell chicken tenders 3Health News:Primary biliary cirrhosis more severe in African-American and Hispanic patients 2Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With KidsFirst-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 BillionOver 500,000 Health Care Providers Now Cutting Costs, Saving Time Through CAQH Administrative Simplification InitiativeFarewell chicken tendersPrimary biliary cirrhosis more severe in African-American and Hispanic patientsMold linked to asthma
(Date:11/19/2009)... 19 In a series of new i...eska Corporation (Nasdaq: HSKA ) ("Heska" or the ...nd improved website. The upgraded site is the res...ramming to align the site with the company,s new b... http://www.newscom.com/cgi-bin/prnh/20000622/HE...
(Date:11/19/2009).... 19 The D e al maga... Most Admired Corporate Dealmakers for the second ...s Most Admired Dealmaker in pharma/biotech for the...divestitures since January 2006. ,, Over the pa...lio with a focus on high-growth, innovation-driven...
(Date:11/19/2009).... 19 Mach 7 Technologies, a glob...mage management solutions, and QStar Technologies ...S- neutral archive solution through their common U...rnational leader in providing digital image distri...stry. Under the agreement, Data Distributing will...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 1New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 2New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 1MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 4MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 5MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 6MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 7Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board 53453 1Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board 53453 2...ternative Five-day Dosing Schedules Appear Similar...sion Independence, Hematologic Improvement ...resented at the 49th American Society of Hematolog...ration,(Nasdaq: PHRM ) today announced interim da...alternative five-day dosing schedules for Vidaza(R...
... Heart Association/American College of Cardiology ...s care, treatment for heart attacks, DALLAS, Dec....ts of heart attack care has prompted the American ...on to update portions of their,joint guidelines fo...ation,myocardial infarction (STEMI)., For release...
Other Medicine Technology:MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6News from the American Heart Association 2News from the American Heart Association 3News from the American Heart Association 4News from the American Heart Association 5Retinal Foerester Pick: 55 Angled Sharp Tip
Retinal Angled Pick: 0.5mm 130 Tip Angle
Retinal Lagua Pick: 2.0mm Vertical Notch
Retinal Angled Spatula: Triangular 0.5mm Tip, 4.0mm Surface 130
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |